High levels of HSF1 expression in tumor tissues has been reported to be associated with poor progression in patients with breast cancer [16], endometrial carcinoma [11], hepatocellular carcinoma [17] and Hodgkin’s lymphoma [18]. Here, HSF1 is linked to hepatocellular carcinoma.